As a 'Virtual' Drug Discovery company, MitoDys has assembled an internationally recognised group of experts who act as both advisors as well as experimental 'validators' and clinical trial investigators obviating the need for internal resources.  All preclinical, regulatory and clinical work will be outsourced either to our network of experts or to selected, contracted expert intermediaries. The overall process will be monitored and managed by MitoDys' team supported by a Board of seasoned executives with both big Pharma and smaller entrepreneurial biotech experience.